Recruiting NA Cartilage Injury

New treatment option for Cartilage Injury

Official title Tissue Engineered Cartilage to Repairing Articular Cartilage Defects

ClinicalTrials.gov ID: NCT07094100

What this study is testing

What it's testing
The joint cartilage constructed by combining bone marrow mesenchymal stem cells with three-dimensional materials has achieved the goal of repairing joint cartilage.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • The patients' age ranges from 18 to 65 years old, and gender is not restricted;
  • The imaging results show that the epiphyseal growth is mature;
  • The defects or localized injuries of joint cartilage caused by trauma or other reasons;
  • The injured area is the distal weight-bearing surface of the femoral condyle of the knee joint, with no more than 4 lesions, and there is no injury...
  • The patients voluntarily sign and provide a written informed consent form and are willing to closely cooperate with the doctor's strict postoperative...

You likely can't join if

  • The patient is extremely overweight, with a body mass index greater than 35;
  • The lower limb alignment is valgus by more than 10° and varus by more than 5°;
  • Multiple ligament injuries;
  • There are numerous bad habits such as heavy smoking, drug abuse, and excessive alcohol consumption;
  • Has undergone open knee joint surgery within the past six months;
  • Has severe joint stiffness or fibrosis;
See the full eligibility criteria
Who can join
  • The patients' age ranges from 18 to 65 years old, and gender is not restricted;
  • The imaging results show that the epiphyseal growth is mature;
  • The defects or localized injuries of joint cartilage caused by trauma or other reasons;
  • The injured area is the distal weight-bearing surface of the femoral condyle of the knee joint, with no more than 4 lesions, and there is no injury to the cruciate ligaments;
  • The patients voluntarily sign and provide a written informed consent form and are willing to closely cooperate with the doctor's strict postoperative rehabilitation program.
What rules you out
  • The patient is extremely overweight, with a body mass index greater than 35;
  • The lower limb alignment is valgus by more than 10° and varus by more than 5°;
  • Multiple ligament injuries;
  • There are numerous bad habits such as heavy smoking, drug abuse, and excessive alcohol consumption;
  • Has undergone open knee joint surgery within the past six months;
  • Has severe joint stiffness or fibrosis;
  • Has an allergic constitution or a history of allergic reactions to collagen;
  • Has mental abnormalities;
  • Cannot or is unwilling to undergo rehabilitation training;
  • Has primary cardiovascular diseases, lung diseases, endocrine and metabolic disorders, or other serious diseases that affect their daily life, such as tumors or AIDS;
  • Pregnant or lactating women, or those planning to conceive during the trial period;
  • Other acute or chronic diseases, for which the researchers consider surgery to be inappropriate.

The study team makes the final eligibility decision.

Where it's taking place

  • Xinxiang, Henan, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Xinxiang, Henan, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.